Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: FUTURE 3 Study Extension [Phase 3]
Actelion reported the FUTURE 3 study extension for pulmonary arterial hypertension has completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension [Phase 2]
A Phase 2 trial evaluating different oral doses of PF-00489791 for adults with pulmonary arterial hypertension was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Efficacy of Ventavis Used in Real-life Setting.
This clinical trial update reports on the real-world efficacy of Ventavis (iloprost) for pulmonary arterial hypertension.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH) [Phase 4]
A Phase 4 clinical trial update reports results for a thermostable epoprostenol sodium formulation intended to treat pulmonary arterial hype…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION) [Phase 4]
A Phase 4 trial (MOTION) evaluating outcomes in patients with pulmonary arterial hypertension not on active treatment has completed, with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis [Phase 4]
Phase 4 clinical trial update evaluating ambrisentan and tadalafil in pulmonary arterial hypertension associated with systemic sclerosis; st…
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) [Phase 4]
Phase 4 safety and tolerability study evaluating rapid dose titration of subcutaneous Remodulin in patients with pulmonary arterial hyperten…
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication [Phase 4]
A Phase 4 clinical trial reports results on transitioning patients from injectable prostacyclin therapy to inhaled prostacyclin therapy for …
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) [Phase 4]
Phase 4 trial update on intravenous Remodulin (treprostinil) in Indian PAH patients; study completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension [Phase 2]
A Phase 2 study evaluating aspirin and simvastatin for pulmonary arterial hypertension was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography [NA]
A completed clinical trial evaluating non-invasive diagnostics for pulmonary hypertension using dual-energy computed tomography.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography [NA]
A completed clinical study from the Medical University of Graz evaluated non-invasive diagnostics of pulmonary arterial hypertension using d…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up
A completed clinical trial update on the NIMS implantable pump for pulmonary arterial hypertension, focusing on safety follow-up.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension [Phase 3]
A Phase 3 trial comparing two dosing regimens of bosentan in children with pulmonary arterial hypertension has completed, and results have b…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Pulmonary Artery Involvement in Takayasu's Arteritis
A clinical trial evaluating pulmonary artery involvement in Takayasu arteritis has completed; no results are described in the provided snipp…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension [Phase 1, Phase 2]
A pilot Phase 1/2 study evaluating the safety and efficacy of carvedilol in pulmonary arterial hypertension, with results posted in June 201…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice
This completed study evaluated real-world treatment patterns in patients with pulmonary arterial hypertension or chronic thromboembolic pulm…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH) [Phase 4]
Phase 4 open-label study assessing safety and efficacy of ambrisentan in exercise-induced pulmonary arterial hypertension completed with pos…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension [Phase 3]
Phase 3 clinical trial assessing how long-term oxygen therapy affects exercise capacity and quality of life in patients with pulmonary arter…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery
Duke University-sponsored trial evaluating symptomatic pulmonary arterial hypertension after mitral valve surgery has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude [Phase 4]
A Phase 4 clinical trial evaluating riociguat's effects on exercise performance and pulmonary artery pressure at high altitude; the study wa…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects [Phase 4]
Phase 4 study evaluating a thermostable formulation of FLOLAN (epoprostenol) in Japanese patients with pulmonary arterial hypertension, with…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension [Phase 4]
Phase 4 trial evaluating safety and efficacy of sildenafil in children with pulmonary arterial hypertension has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Insulin Resistance in Pulmonary Arterial Hypertension [Phase 2]
A Phase 2 trial investigating insulin resistance in pulmonary arterial hypertension was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Bosentan in Children With Pulmonary Arterial Hypertension Extension Study [Phase 3]
This update covers the completion and results posting of a Phase 3 extension study of bosentan in children with pulmonary arterial hypertens…